Aarti Pharmalabs Limited

Equities

Market Closed - NSE India S.E. Other stock markets 07:05:01 2026-03-09 am EDT			5-day change	1st Jan Change
681.05 ^INR	-2.73%		-5.89%	-9.48%

Feb. 10	Aarti Pharmalabs Limited, Q3 2026 Earnings Call, Feb 10, 2026
Feb. 09	Aarti Pharmalabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Published on 11/11/2025 at 12:35 pm EST - Modified on 11/27/2025 at 12:23 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to Aarti Pharmalabs Q2 and H1 FY '26 Earnings Conference Call hosted by Emkay Global Financial Services

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Feb. 10	Aarti Pharmalabs Limited, Q3 2026 Earnings Call, Feb 10, 2026
Feb. 09	Aarti Pharmalabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
Feb. 09	Aarti Pharmalabs interim dividend of 1.50 rupee per equity share	RE
Feb. 09	Aarti Pharmalabs posts Dec-qtr consol net profit 479.6 million rupees	RE
Feb. 09	Aarti Pharmalabs Limited Declares Interim Dividend for the Financial Year 2025-26	CI
Jan. 01	Aarti Pharmalabs Limited Appoints Dr. Rakeshwar Bandichhor as Chief Scientific Officer ? R&D and Senior Management Personnel, Effective January 1, 2026	CI
Nov. 11	Aarti Pharmalabs Limited, Q2 2026 Earnings Call, Nov 11, 2025
Nov. 09	Aarti Pharmalabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
Nov. 09	Aarti Pharmalabs Limited Announces Executive Appointments, Effective November 10, 2025	CI
25-09-03	Indian Equities Rise on Wednesday on GST Cuts Hopes	MT
25-09-03	Aarti Pharmalabs Inaugurates New Manufacturing Unit in Gujarat, India	MT
25-09-03	Aarti Pharmalabs Limited Inaugurates Its New Manufacturing Facility at Atali, Gujarat to Expand Its Production Capacity	CI
25-08-13	Aarti Pharmalabs Limited, Q1 2026 Earnings Call, Aug 13, 2025
25-08-12	Aarti Pharmalabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-08-12	Aarti Pharmalabs June-quarter consol net profit 495 million rupees	RE

Duration

Period

Sector